Skip to main content
All lobbying filings

MEDTRONIC, INC.

Lobbying for MEDTRONIC INC

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $990,000.00 expenses · posted Jan 20, 2026

Official filing document

 Bills named in this filing 10
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S 1399
    Health Tech Investment Act
  • HR 6197
    Health Tech Investment Act
  • HR 1539
    Medical Device Electronic Labeling Act
  • S 2296
    National Defense Authorization Act for Fiscal Year 2026
  • HR 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
  • S 1553
    PREVAIL Act
  • S 1546
    Patent Eligibility Restoration Act of 2025
  • S 708
    RESTORE Patent Rights Act of 2025
 Lobbying activity 12
Budget/Appropriations

Issues related to hypertension, including FY26 MilCon/Veterans Appropriations

Medicare/Medicaid

Issues related to Medicare coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) Issues related to Medicare coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to Medicare Physician Fee Schedule Issues related to prior authorization, including CMMI WISeR Model Issues related to Medicare competitive bidding

Taxation/Internal Revenue Code

Issues related to the taxation of multinational corporations corporations

Trade (domestic/foreign)

Issues related to global supply chains including rare earth and critical minerals Issues related to tariffs

Health Issues

Issues related to medical device electronic labeling, including H.R. 1539 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices, including S.2296 - National Defense Authorization Act for Fiscal Year 2026 and H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 Issues related to artificial intelligence and other advanced software in health care Issues related to Parkinsons disease Issues related to diabetes Issues related to epilepsy Issues related to overactive bladder and urinary incontinence

Telecommunications

Issues related to cybersecurity, including reauthorization of the Cybersecurity Information Sharing Act of 2015

Labor Issues/Antitrust/Workplace

Issues related to anti-trust and competition

Copyright/Patent/Trademark

Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025

Environment/Superfund

Monitoring Environmental, Social and Governance (ESG) issues Issues related to the sterilization of medical devices Issues related to the use of polyfluoroalkyl substances

Consumer Issues/Safety/Products

Issues related to data privacy and data security Issues related to artificial intelligence enabled medical devices and emerging technologies Issues related to right to repair

Veterans

Issues related to hypertension Issues related to procurement of healthcare technologies

Defense

Issues related to S.2296 - National Defense Authorization Act for Fiscal Year 2026 and H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 including servicing and repair of medical devices, outbound investment and BIOSECURE

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem